![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 15, 2014 10:42:12 PM
Gerald has many good problems; what does he progress and move forward with this rich pipeleine:
1) LymPro - commercialize or sell the division? $$$$
2) Phenoguard partnership = $$$$ (John C. mentioned that it could be partnered in early 2014)
3) PD Lid compound - start Phase 2b trials within months; immediate boost to market capitalization (bought for peanuts = $100k).
4) Retinonis Pigmentosis Orphan - partner with a Pharma - $$$$
5) Attract high quality financing - Wall street readjusts the current market capitalization upward as many assets can be advanced immediately.
6) Wolframs Diabetes Orphan/Type 2 Diabetes - partner with a Pharma - $$$$
7) TBI - big stuff coming later in Jan. (stake is already in the ground); possible big grants coming there. NFL, Govt. or Banyan Biomarkers
8) Another Orphan data announcement - Ischemic Heart disease or a surprise announcement.
Does it get any better than this folks? Wow!!!
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM